AMG 172 First in Human Study in Patients With Kidney Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT01497821
First received: December 16, 2011
Last updated: March 23, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)